de Freitas, J. T., Thakur, V., LaPorte, K. M., Thakur, V. S., Flores, B., Caicedo, V., . . . Bedogni, B. (2024). Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME. Journal of Experimental & Clinical Cancer Research (17569966), 43(1), 1. https://doi.org/10.1186/s13046-024-03214-5
Chicago Style (17th ed.) Citationde Freitas, Juliano Tiburcio, et al. "Notch1 Blockade by a Novel, Selective Anti-Notch1 Neutralizing Antibody Improves Immunotherapy Efficacy in Melanoma by Promoting an Inflamed TME." Journal of Experimental & Clinical Cancer Research (17569966) 43, no. 1 (2024): 1. https://doi.org/10.1186/s13046-024-03214-5.
MLA (9th ed.) Citationde Freitas, Juliano Tiburcio, et al. "Notch1 Blockade by a Novel, Selective Anti-Notch1 Neutralizing Antibody Improves Immunotherapy Efficacy in Melanoma by Promoting an Inflamed TME." Journal of Experimental & Clinical Cancer Research (17569966), vol. 43, no. 1, 2024, p. 1, https://doi.org/10.1186/s13046-024-03214-5.